MARKET

ARPO

ARPO

Aerpio Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.020
-0.030
-1.46%
After Hours: 2.000 -0.02 -0.99% 19:53 08/03 EDT
OPEN
2.050
PREV CLOSE
2.050
HIGH
2.060
LOW
1.990
VOLUME
566.29K
TURNOVER
--
52 WEEK HIGH
3.320
52 WEEK LOW
0.9541
MARKET CAP
95.90M
P/E (TTM)
-23.8208
1D
5D
1M
3M
1Y
5Y
DPW, ANVS and CFMS among pre market gainers
Socket Mobile (SCKT) +79% on Q2 earningsAlzamend Neuro (ALZN) +62% after data showing safety of Alzheimer’s therapy in mouse studyVeoneer (VNE) +55% on earningsAcorda Therapeutics (ACOR) +49% on INBRIJA distribution and supply dealNRx Pharmaceuticals (NRXP...
Seekingalpha · 07/23 12:30
Glaukos, Stable Road Acquisition, Pop Culture Group among premarket losers' pack
Allied Healthcare Products (AHPI) -24%.Glaukos (GKOS) -21% comments on the centers for medicare and medicaid services 2022 proposed physician fee scheduleAllena Pharmaceuticals ALNA -20% after launches $28M direct offeringIMARA IMRA -15% after secures $50M...
Seekingalpha · 07/14 12:20
64 Biggest Movers From Yesterday
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday.
Benzinga · 07/14 08:50
Aerpio Pharmaceuticals, GlycoMimetics, Digital Brands among premarket losers' pack
ToughBuilt Industries (TBLT) -29% ToughBuilt Industries launches $40M direct offeringAerpio Pharmaceuticals (ARPO) -8%.Nova LifeStyle (NVFY) -9%.UTStarcom Holdings (UTSI) -7%.GlycoMimetics (GLYC) -6%.Digital Brands Group (DBGI) -5%.
Seekingalpha · 07/12 12:29
64 Biggest Movers From Friday
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share.
Benzinga · 07/12 09:16
Alector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rally
naphtalina/iStock via Getty Images COVID-19-related headlines dominated the holiday-shortened week as the Delta variant of the virus renewed pandemic fears across the globe. Meanwhile, with a ~1.3% gain over the past five-day period, the
Seekingalpha · 07/10 22:51
STMP, MMAT, GALT among mid-day movers
Gainers: SGOCO Group (SGOC) +250%.Stamps.com STMP +64%.ToughBuilt Industries TBLT +48%.Carver Bancorp CARV +39%.Galectin Therapeutics GALT +33%.Tempest Therapeutics (TPST) +20%.Sequential Brands Group (SQBG) +19%.LMP Automotive LMPX +18%.Grupo Simec, S.A.B...
Seekingalpha · 07/09 17:24
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 07/09 16:35
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ARPO. Analyze the recent business situations of Aerpio Pharms through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ARPO stock price target is 22.00 with a high estimate of 22.00 and a low estimate of 22.00.
EPS
Institutional Holdings
Institutions: 50
Institutional Holdings: 26.64M
% Owned: 56.11%
Shares Outstanding: 47.48M
TypeInstitutionsShares
Increased
10
3.92M
New
10
4.45M
Decreased
10
1.17M
Sold Out
8
407.08K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About ARPO
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications. Its lead product candidate is razuprotafib. Razuprotafib, is a small molecule VE-PTP inhibitor, an enzyme that is upregulated in diabetic eye disease and that is responsible for inactivating Tie2. The Company is also developing a bispecific antibody that binds both VEGF and VE-PTP, which is designed to inhibit VEGF activation and activate Tie2. The Company's pipeline includes Razuprotafib (AKB-9778) Open Angle Glaucoma, Razuprotafib Acute Respiratory Distress Syndrome (ARDS)/ COVID-19, Razuprotafib Diabetic Kidney Disease, ARP-1536 Retinopathy/Nephropathy and Bispecific Ab Retinopathy/Cancer.

Webull offers kinds of Aerpio Pharmaceuticals Inc stock information, including NASDAQ:ARPO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARPO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ARPO stock methods without spending real money on the virtual paper trading platform.